Physician profile
Sean Griffiths
NPI 1457705667
$12,195.16
in general payments reported to CMS, 2019-2025
12 companies · $688 in 2025
The $688 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $358 · 2022: $747 · 2023: $2,250 · 2024: $8,152 · 2025: $688.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,703 · Food and Beverage: $1,950 · Travel and Lodging: $1,437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,702.50 |
| Food and Beverage | $1,950.18 |
| Travel and Lodging | $1,437.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $7,913.40 | 2022-2024 | |
| Zimmer Biomet Holdings, INC. | $2,785.71 | 2023-2025 | Rosa, Avenir, Persona |
| Stryker Corporation | $1,095.02 | 2021-2024 | T2 Alpha, Variax |
| Davol INC. | $105.66 | 2022 | |
| Medacta USA, INC. | $93.42 | 2023 | Gmk Sphere |
| Depuy Synthes Sales INC. | $46.82 | 2024 | Attune, Orthovisc, Monovisc |
| Heron Therapeutics, INC. | $39.20 | 2023-2025 | Zynrelef |
| Orthofix Medical, INC. | $36.55 | 2025 | Physio-Stim |
| Fidia Pharma USA INC. | $23.97 | 2023 | Triluron, Hymovis |
| Si-Bone, INC. | $20.17 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $18.31 | 2025 | |
| Linvatec Corporation | $16.93 | 2025 | Anchor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Griffiths listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.